GLP-1 Science
What Is a GLP-1 Receptor Agonist? A Simple Explanation
GLP-1 receptor agonists are drugs that mimic the fullness hormone GLP-1. Ozempic, Wegovy, and Mounjaro are all in this c...
Semaglutide works by activating GLP-1 receptors across multiple organ systems simultaneously. It does not work through a single simple pathway — it produces weight loss through at least four distinct mechanisms that reinforce each other. Understanding each one explains why semaglutide is more effective than older weight loss approaches that targeted only one pathway.
Step 1: Mimicking Your Own Hunger Hormone
Semaglutide is a synthetic analogue of GLP-1 — the glucagon-like peptide-1 hormone your gut produces naturally after every meal. Natural GLP-1 is broken down within two to three minutes of release. Semaglutide is engineered to resist this breakdown, giving it a half-life of approximately one week.
By binding to GLP-1 receptors continuously throughout the week, semaglutide produces persistent activation of the same signalling system that naturally creates post-meal fullness — but without any meal being required to trigger it.
Step 2: Reducing Hunger at the Brain Level
GLP-1 receptors are present in the hypothalamus — the brain's primary hunger and energy regulation centre. Semaglutide crosses the blood-brain barrier and directly activates these receptors.
The result is reduced activity in the areas of the brain responsible for hunger perception and food-reward signalling. People on semaglutide report genuinely lower interest in food between meals, not just reduced calorie intake despite ongoing hunger. This central mechanism is the primary driver of weight loss — reducing the defended weight set-point rather than just fighting against it.
Step 3: Slowing the Stomach
GLP-1 receptors on the vagus nerve regulate gastric emptying — the rate at which food leaves the stomach. Semaglutide activation slows this process significantly. A meal that previously left the stomach within 90 to 120 minutes takes three to four hours on semaglutide.
This extended gastric retention has two effects. It keeps you physically full for longer after each meal. And it smooths the blood sugar rise that follows eating by releasing glucose into the intestine more gradually.
The stomach-slowing mechanism also produces the most common side effect — nausea — when doses are too high too quickly or when meals are too large or high in fat.
Step 4: Improving Insulin Response
Semaglutide activates GLP-1 receptors on pancreatic beta cells, stimulating insulin release in response to elevated blood sugar. This is glucose-dependent — the drug only triggers insulin when blood sugar is actually elevated, which is why it does not cause hypoglycaemia when used alone.
Simultaneously, semaglutide suppresses glucagon — the hormone that tells the liver to release stored glucose. Reducing glucagon alongside increasing insulin produces smoother, lower blood sugar peaks after meals, which reduces the blood sugar crashes that trigger hunger and carbohydrate cravings in the hours after eating.
How These Mechanisms Combine
The brain effect reduces how hungry you feel. The stomach effect extends how long each meal keeps you satisfied. The insulin effect reduces the blood sugar cycle that drives between-meal hunger. These three effects work together to substantially reduce daily calorie intake without the effort or discomfort of conscious restriction.
The weight loss result is not from burning more calories — semaglutide does not meaningfully increase metabolic rate. It works entirely through reducing intake, and it does so through mechanisms that align with the body's own regulatory system rather than fighting against it.
Same Mechanism, Sublingual Delivery
Every mechanism described above is activated through GLP-1 receptor engagement — regardless of how GLP-1 reaches the receptor. METASLIM GLP-1 sublingual drops deliver GLP-1 under the tongue, absorbing directly into the bloodstream without injection. The hypothalamic satiety signalling, the gastric emptying slowdown, and the insulin response improvement all follow from the same receptor pathway — whether activated by injectable semaglutide or sublingual GLP-1 support.